Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hippo Holdings (HIPO) Research & Development (2020 - 2025)

Hippo Holdings' Research & Development history spans 6 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Research & Development rose 9.21% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $32.5 million, up 5.86%, while the annual FY2025 figure was $32.5 million, 5.86% up from the prior year.
  • Research & Development reached $8.3 million in Q4 2025 per HIPO's latest filing, up from $8.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $16.5 million in Q2 2022 to a low of $6.9 million in Q1 2021.
  • Average Research & Development over 5 years is $10.2 million, with a median of $8.3 million recorded in 2021.
  • Peak YoY movement for Research & Development: soared 181.25% in 2021, then plummeted 41.18% in 2024.
  • A 5-year view of Research & Development shows it stood at $13.5 million in 2021, then fell by 14.81% to $11.5 million in 2022, then fell by 9.57% to $10.4 million in 2023, then fell by 26.92% to $7.6 million in 2024, then grew by 9.21% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for HIPO's Research & Development are $8.3 million (Q4 2025), $8.0 million (Q3 2025), and $8.1 million (Q2 2025).